Eurobio Scientific Logo

Eurobio Scientific

Specializes in in vitro diagnostics for transplantation, oncology, and infectious diseases.

ALERS | PA

Overview

Corporate Details

ISIN(s):
FR0004054435 (+2 more)
LEI:
969500IQEUEH806GE257
Country:
France
Address:
7 AVENUE DE SCANDINAVIE, 91940 LES ULIS

Description

Eurobio Scientific is an integrated company specializing in in vitro diagnostics (IVD). Its activities cover the entire value chain, from research and development to the manufacturing and commercialization of specialty diagnostic products. The company's core focus areas are transplantation, oncology, and infectious diseases. In transplantation, it provides reagents, software for transplant matching and chimerism monitoring, and culture media for cornea grafts. For oncology, it develops and manufactures prognostic genomic tests for breast and prostate cancer. The group also markets a comprehensive portfolio of molecular tests for detecting infectious diseases, alongside solutions for immunology, fertility, and dermatological conditions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-13 18:30
EUROBIO SCIENTIFIC : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025
French 947.6 KB
2025-09-24 17:40
Eurobio Scientific : résultat du 1er semestre 2025
French 270.5 KB
2025-09-24 17:40
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
English 276.5 KB
2025-07-01 17:45
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
French 177.0 KB
2025-07-01 17:45
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
English 173.7 KB
2025-06-17 16:59
Franchissement de seuils
French 116.1 KB
2025-05-19 19:16
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
French 135.1 KB
2025-05-19 19:16
Eurobio Scientific: EB Development rises above 90% threshold
English 134.8 KB
2025-04-29 21:00
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
French 610.9 KB
2025-04-28 17:46
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
French 216.3 KB
2025-04-28 17:46
Eurobio Scientific: 2024 annual results
English 231.2 KB
2025-03-12 17:35
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
French 131.2 KB
2025-03-12 17:35
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
English 133.7 KB
2025-03-04 20:03
Eurobio Scientific : résiliation du contrat de liquidité
French 134.6 KB
2025-01-15 17:46
Eurobio Scientific : calendrier des publications financieres 2025
French 598.6 KB

Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurobio Scientific

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurobio Scientific via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-12-18 N/A Other Buy 1,000 15,180.00 EUR

Peer Companies

Cardiol Therapeutics Inc. Logo
Clinical-stage company developing anti-inflammatory and anti-fibrotic heart therapies.
United States of America
CRDL
CAREGEN CO.,LTD. Logo
Develops biomimetic peptides and growth factors for aesthetic and medical solutions.
South Korea
214370
Caribou Biosciences, Inc. Logo
Clinical-stage biopharma developing genome-edited allogeneic cell therapies.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
A clinical-stage biotech developing engineered macrophage-based therapeutics for cancer.
United States of America
CARM
Carna Biosciences, Inc. Logo
Clinical-stage biopharma developing small molecule kinase inhibitors.
Japan
4572
Cartesian Therapeutics, Inc. Logo
A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Biopharmaceutical firm developing therapeutics for organ transplant and autoimmune diseases.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
United States of America
CPRX
cbdMD, Inc. Logo
Producer and distributor of health and wellness CBD products from U.S.-grown hemp.
United States of America
YCBD
CDT Equity Inc. Logo
A clinical-stage biopharmaceutical firm advancing assets for unmet medical needs.
United States of America
CDT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.